ViroPharma Sees Silver Lining In Maribavir Failure: Now There’s Cash To Go Bargain Hunting

A good candidate would require a limited commercial infrastructure and make use of the company’s knowledge in transplantation, CEO Milano says, trying to redirect attention from the failed antiviral.